Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Conditions: Intractable Epilepsy; Malignant Glioma; Seizure Disorder Interventions: Drug: Phenobarbital, Phenytoin, Carbamazepine, Valproate, Gabapentin, Pregabalin, Lamotrigine, Topiramate, Leviteracetam, Lacosamide, Zonisamide, Clobazam, Oxcarbezepine, Rufinamide; Drug: Perampanel; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 2, 2020 Category: Research Source Type: clinical trials
Safety Study of Rufinamide Given as an add-on Therapy to Treat Patients With Seizures
Condition: Refractory Partial Seizures Intervention: Drug: Rufinamide Sponsor: University of South Alabama Withdrawn (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2020 Category: Research Source Type: clinical trials